메뉴 건너뛰기




Volumn 126, Issue 7, 2008, Pages 1002-1003

Effect of intravitreous rituximab injections in patients with recurrent ocular lesions associated with central nervous system lymphoma

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; METHOTREXATE; RITUXIMAB;

EID: 47549106298     PISSN: 00039950     EISSN: 00039950     Source Type: Journal    
DOI: 10.1001/archopht.126.7.1002     Document Type: Article
Times cited : (54)

References (6)
  • 1
    • 23244461463 scopus 로고    scopus 로고
    • Pathology and genetics of primary central nervous system and intraocular lymphoma
    • Rubenstein JL, Treseler P, O'Brien JM. Pathology and genetics of primary central nervous system and intraocular lymphoma. Hematol Oncol Clin North Am. 2005;19(4):705-717.
    • (2005) Hematol Oncol Clin North Am , vol.19 , Issue.4 , pp. 705-717
    • Rubenstein, J.L.1    Treseler, P.2    O'Brien, J.M.3
  • 2
    • 31644446964 scopus 로고    scopus 로고
    • The pharma-cokinetics of rituximab following an intravitreal injection
    • Kim H, Csaky KG, Chan C-C, et al. The pharma-cokinetics of rituximab following an intravitreal injection. Exp Eye Res. 2006;82(5):760-766.
    • (2006) Exp Eye Res , vol.82 , Issue.5 , pp. 760-766
    • Kim, H.1    Csaky, K.G.2    Chan, C.-C.3
  • 3
    • 37749034029 scopus 로고    scopus 로고
    • Intraocular use of rituximab
    • Kitzmann AS, Pulido JS, Mohney BG, et al. Intraocular use of rituximab. Eye. 2007;21(12):1524-1527.
    • (2007) Eye , vol.21 , Issue.12 , pp. 1524-1527
    • Kitzmann, A.S.1    Pulido, J.S.2    Mohney, B.G.3
  • 4
    • 0036713850 scopus 로고    scopus 로고
    • Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement
    • Smith JR, Rosenbaum JT, Wilson DJ, et al. Role of intravitreal methotrexate in the management of primary central nervous system lymphoma with ocular involvement. Ophthalmology. 2002;109(9):1709-1716.
    • (2002) Ophthalmology , vol.109 , Issue.9 , pp. 1709-1716
    • Smith, J.R.1    Rosenbaum, J.T.2    Wilson, D.J.3
  • 5
    • 37349105294 scopus 로고    scopus 로고
    • Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control
    • Pulido JS, Bakri SJ, Valyi-Nagy T, Shukla D. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control. Retina. 2007;27(8):1071-1073.
    • (2007) Retina , vol.27 , Issue.8 , pp. 1071-1073
    • Pulido, J.S.1    Bakri, S.J.2    Valyi-Nagy, T.3    Shukla, D.4
  • 6
    • 7844225540 scopus 로고    scopus 로고
    • Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma
    • Berinstein NL, Grillo-Lopez AJ, White CA, et al. Association of serum Rituximab (IDEC-C2B8) concentration and anti-tumor response in the treatment of recurrent low-grade or follicular non-Hodgkin's lymphoma. Ann Oncol. 1998;9(9):995-1001.
    • (1998) Ann Oncol , vol.9 , Issue.9 , pp. 995-1001
    • Berinstein, N.L.1    Grillo-Lopez, A.J.2    White, C.A.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.